Summary
Endothelia in the atrioventricular (AV) canal of the developing heart undergo a prototypical epithelial mesenchymal transition (EMT) to begin heart valve formation. Using an in vitro invasion assay, an extracellular matrix protein, Olfactomedin-1 (OLFM1), was found to increase mesenchymal cell numbers in AV canals from embryonic chick hearts. Treatment with both anti-OLFM1 antibody and siRNA targeting OLFM1 inhibits mesenchymal cell formation. OLFM1 does not alter cell proliferation, migration or apoptosis. Dispersion, but lack of invasion in the presence of inhibiting antibody, identifies a specific role for OLFM1 in cell invasion during EMT. This role is conserved in other epithelia, as OLFM1 similarly enhances invasion by MDCK epithelial cells in a transwell assay. Synergy is observed when TGFβ2 and OLFM1 are added to MDCK cell cultures, indicating that OLFM-1 activity is cooperative with TGFβ. Inhibition of both OLFM1 and TGFβ in heart invasion assays shows a similar cooperative role during development. To explore OLFM1 activity during EMT, representative EMT markers were examined. Effects of OLFM1 protein and anti-OLFM1 on transcripts of cell-cell adhesion molecules and the transcription factors Snail-1, Snail-2, Twist1 and Sox-9 argue that OLFM1 does not initiate EMT. Rather, regulation of transcripts of Zeb1 and Zeb2, secreted proteases and mesenchymal cell markers by both OLFM1 and anti-OLFM1 is consistent with regulation of the cell invasion step of EMT. We conclude that OLFM1 is present and necessary during EMT in the embryonic chick heart. Its role in cell invasion and mesenchymal cell gene regulation suggests an invasion checkpoint in EMT where OLFM1 acts to promote cell invasion into the three-dimensional matrix.
- Received July 20, 2012.
- Accepted December 12, 2012.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Featured article - Generation of a multipurpose Prdm16 mouse allele by targeted gene trapping
This Research article from Bryan C. Bjork and co-workers describes the first targeting of an invertible gene trap to generate a conditional Prdm16 mouse allele and its use to assess phenotypic consequences of Prdm16 loss during craniofacial and brain development.
Review - Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
Elena Sommariva and colleagues reappraise past discoveries in in vitro models of arrhythmogenic cardiomyopathy (ACM) in this Review, providing insights into the molecular mechanisms of this disease.
Editor’s choice - Small-molecule therapeutic boosts spatial memory and motor function in Rett syndrome mice
Rett syndrome is caused by a mutation triggering decreased levels of protein BDNF. Small-molecule BDNF mimetic, LM22A-4, has previously been shown to improve respiratory problems associated with the disease. Now, new research from Lucas Pozzo-Miller and colleagues reveals that LM22A-4 may also improve spatial memory and motor skill defects in a Rett syndrome mouse model. Read the Research article here, and the press release here.
Featured article - Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routes
In this Research article from Gabriella Passoni and co-workers, imaging of neuroinvasion in zebrafish shows that chikungunya virus first infects the blood-brain barrier, whereas Sindbis virus relies on axonal transport.
Why should you publish your next paper in Disease Models & Mechanisms?
From single-celled organisms to patient-derived models, cancer to neurodegeneration, Disease Models & Mechanisms publishes the best original research and resources that focus on the use of model systems to better understand, diagnose and treat human disease. Submit your paper here.
Transfer to Biology Open
If your submission to Disease Models & Mechanisms is unsuccessful, did you know you can transfer your paper and any reviews directly to our sister journal, Biology Open? The majority of papers transferred with reviews are accepted for publication. Find out how here.